Status:

RECRUITING

The Pathogenesis and Natural History of Sjogren's Disease

Lead Sponsor:

National Institute of Dental and Craniofacial Research (NIDCR)

Conditions:

Sjogren's Syndrome

Salivary Gland

Eligibility:

All Genders

16-100 years

Brief Summary

Background: -Sjogren s Disease (formerly: Sjogrens Syndrome, Sj(SqrRoot)(Delta)gren s syndrome) is a disease that affects about 1-4 million Americans. It is more common in women. It mainly affects th...

Detailed Description

Background Sjogren's Disease (SjD; formely Sjogren's Syndrome) is an autoimmune disease characterized by chronic inflammation involving the exocrine glands. Salivary and lacrimal glands are predomina...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Ability to sign informed consent form
  • Fulfilling one the definitions below:
  • Sjogren s defined by European-American (EA) classification criteria for primary or secondary Sjogren s Disease (SjD group)
  • Excluded from the EA criteria because of a comorbid condition but otherwise fulfilling the European-American classification criteria (EA excluded SjD group)
  • Incomplete SjD
  • i. at least 2 of the EA criteria with a common manifestation of SjD not included in these criteria (e.g., fatigue, vasculitis, arthritis, etc) or
  • ii. 2 or more common manifestations of SjD which are not included in the EA criteria (e.g.,: fatigue, vasculitis, arthritis, autonomic dysfunction, etc ) and are not explained by other conditions
  • EXCLUSION CRITERIA:
  • <!-- -->
  • Age \<16 years
  • inability or unwillingness to comply with follow up requirements
  • Any medical or psychological/psychiatric condition or treatment that, in the opinion of the Principal Investigator, would exclude the subjects from the research studies (e.g., alternative explanation for subjects signs and symptoms)
  • NIH employees who report directly to the principal investigator or who are a co-worker or relative of the principal investigator.

Exclusion

    Key Trial Info

    Start Date :

    January 18 2012

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    Estimated Enrollment :

    300 Patients enrolled

    Trial Details

    Trial ID

    NCT01425892

    Start Date

    January 18 2012

    Last Update

    January 8 2026

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892